Podcast
Questions and Answers
Which of the following is true regarding mycobacteria?
Which of the following is true regarding mycobacteria?
- They have a gram-negative cell wall structure.
- They are acid-fast due to mycolic acid in their cell wall. (correct)
- They all grow rapidly in culture.
- They are all pathogenic to humans.
What is the approximate number of people infected with latent TB worldwide?
What is the approximate number of people infected with latent TB worldwide?
- 2 billion (correct)
- 200 million
- 2 million
- 20 billion
Which of the following is a common symptom of active TB disease?
Which of the following is a common symptom of active TB disease?
- Weight gain
- Increased appetite
- Night sweats (correct)
- Improved energy levels
A positive tuberculin skin test (PPD) indicates what?
A positive tuberculin skin test (PPD) indicates what?
Which characteristic is associated with Mycobacterium tuberculosis?
Which characteristic is associated with Mycobacterium tuberculosis?
What is the primary target organ for TB infections?
What is the primary target organ for TB infections?
Which diagnostic method is used to monitor the treatment progress of TB?
Which diagnostic method is used to monitor the treatment progress of TB?
Which of the following is a key component of the mycobacterial cell wall and contributes to its unique characteristics?
Which of the following is a key component of the mycobacterial cell wall and contributes to its unique characteristics?
Which of the following is a common first-line drug used in the treatment of drug-sensitive tuberculosis?
Which of the following is a common first-line drug used in the treatment of drug-sensitive tuberculosis?
What is the primary mechanism by which Isoniazid (INH) inhibits mycobacterial growth?
What is the primary mechanism by which Isoniazid (INH) inhibits mycobacterial growth?
Which of the following is a common adverse effect associated with ethambutol?
Which of the following is a common adverse effect associated with ethambutol?
Which of the following is a potential consequence of spontaneous mutations in M. tuberculosis?
Which of the following is a potential consequence of spontaneous mutations in M. tuberculosis?
What strategy aimed at preventing the development of drug resistance in tuberculosis involves directly watching patients take their medication?
What strategy aimed at preventing the development of drug resistance in tuberculosis involves directly watching patients take their medication?
When treating tuberculosis, why is it important to avoid adding a single drug to a failing regimen?
When treating tuberculosis, why is it important to avoid adding a single drug to a failing regimen?
Which of the following is a key characteristic of rifamycins like rifampin?
Which of the following is a key characteristic of rifamycins like rifampin?
What is a common mechanism of resistance to rifampin in Mycobacterium tuberculosis?
What is a common mechanism of resistance to rifampin in Mycobacterium tuberculosis?
What is the primary mechanism of action of pyrazinamide?
What is the primary mechanism of action of pyrazinamide?
Which of the following regarding Non-tuberculous mycobacteria (NTM) is true?
Which of the following regarding Non-tuberculous mycobacteria (NTM) is true?
Which of the following is a common source of nontuberculous mycobacteria (NTM) that can lead to infection?
Which of the following is a common source of nontuberculous mycobacteria (NTM) that can lead to infection?
In the context of NTM infections, what does MAC stand for?
In the context of NTM infections, what does MAC stand for?
Which term describes mycobacteria that are neither M. tuberculosis nor M. bovis?
Which term describes mycobacteria that are neither M. tuberculosis nor M. bovis?
A patient is diagnosed with a non-tuberculous mycobacterial (NTM) infection. Which of the following factors would increase the risk for this type of infection?
A patient is diagnosed with a non-tuberculous mycobacterial (NTM) infection. Which of the following factors would increase the risk for this type of infection?
What is the difference between latent TB infection (LTBI) and active TB disease?
What is the difference between latent TB infection (LTBI) and active TB disease?
How is tuberculosis primarily transmitted from one person to another?
How is tuberculosis primarily transmitted from one person to another?
Which of the following is a diagnostic test used to detect latent TB infection?
Which of the following is a diagnostic test used to detect latent TB infection?
Which term describes TB that is resistant to at least isoniazid and rifampin?
Which term describes TB that is resistant to at least isoniazid and rifampin?
What is the significance of granuloma formation in TB infection?
What is the significance of granuloma formation in TB infection?
Why is combination therapy used to treat Tuberculosis?
Why is combination therapy used to treat Tuberculosis?
What is the role of the katG gene in isoniazid (INH) resistance?
What is the role of the katG gene in isoniazid (INH) resistance?
What is the purpose of using pyridoxine (vitamin B6) when treating patients with isoniazid (INH)?
What is the purpose of using pyridoxine (vitamin B6) when treating patients with isoniazid (INH)?
Which of the following is a potential drug interaction associated with rifampin?
Which of the following is a potential drug interaction associated with rifampin?
Which of the following refers to TB disease outside the lungs?
Which of the following refers to TB disease outside the lungs?
In HIV-positive patients with TB, if not receiving ART, what modification to the TB treatment is recommended to prevent the occurance of IRIS?
In HIV-positive patients with TB, if not receiving ART, what modification to the TB treatment is recommended to prevent the occurance of IRIS?
What is the main component for NTM infections?
What is the main component for NTM infections?
What is meant by the term 'prodrug'?
What is meant by the term 'prodrug'?
What component of bacterial cell wall is targeted by Ethambutol?
What component of bacterial cell wall is targeted by Ethambutol?
If a patient is macrolide resistant, what type of medication would be used?
If a patient is macrolide resistant, what type of medication would be used?
What is needed for treating Mycobacterium ulcerans?
What is needed for treating Mycobacterium ulcerans?
What is the most likely cause of treatment failures?
What is the most likely cause of treatment failures?
Which of the following is true for Macrolides?
Which of the following is true for Macrolides?
What characteristic do mycobacteria possess due to their cell wall composition?
What characteristic do mycobacteria possess due to their cell wall composition?
Which of the following is a species of pathogenic mycobacteria other than M. tuberculosis?
Which of the following is a species of pathogenic mycobacteria other than M. tuberculosis?
What is the term for the group of mycobacteria that are not M. tuberculosis or M. bovis?
What is the term for the group of mycobacteria that are not M. tuberculosis or M. bovis?
Which term describes mycobacteria that can be found almost everywhere?
Which term describes mycobacteria that can be found almost everywhere?
What is the typical duration of treatment for drug-sensitive tuberculosis using current daily regimens?
What is the typical duration of treatment for drug-sensitive tuberculosis using current daily regimens?
What is a potential consequence of spontaneous mutations in M. tuberculosis?
What is a potential consequence of spontaneous mutations in M. tuberculosis?
What does DOTS stand for in the context of TB treatment strategies?
What does DOTS stand for in the context of TB treatment strategies?
Isoniazid inhibits the synthesis of what?
Isoniazid inhibits the synthesis of what?
Which of the following is a first-line TB agent that is a bacterial-activated prodrug?
Which of the following is a first-line TB agent that is a bacterial-activated prodrug?
What supplement is often given with isoniazid to prevent peripheral neuritis?
What supplement is often given with isoniazid to prevent peripheral neuritis?
Mutations in which bacterial component leads to Isoniazid resistance?
Mutations in which bacterial component leads to Isoniazid resistance?
How does rifampin affect other drugs in the body?
How does rifampin affect other drugs in the body?
Rifampin works by binding to the beta subunit of what?
Rifampin works by binding to the beta subunit of what?
What is a common adverse reaction associated with ethambutol?
What is a common adverse reaction associated with ethambutol?
What cell wall component is targeted by ethambutol?
What cell wall component is targeted by ethambutol?
What is the primary source of NTM in the environment?
What is the primary source of NTM in the environment?
Which of the following is a common route of acquiring NTM infections?
Which of the following is a common route of acquiring NTM infections?
What underlying condition increases the risk of nontuberculous mycobacterial (NTM) infection?
What underlying condition increases the risk of nontuberculous mycobacterial (NTM) infection?
Which of the following species is associated with Buruli ulcers?
Which of the following species is associated with Buruli ulcers?
What antibiotic regimen is recommended for treating Mycobacterium ulcerans?
What antibiotic regimen is recommended for treating Mycobacterium ulcerans?
Which term describes the ability of some bacteria, including mycobacteria, to survive in a dormant state and then become active?
Which term describes the ability of some bacteria, including mycobacteria, to survive in a dormant state and then become active?
NTM can lead to infection, especially in patients with what condition?
NTM can lead to infection, especially in patients with what condition?
If a patient has a macrolide susceptible MAC, which class of antibiotics would be used?
If a patient has a macrolide susceptible MAC, which class of antibiotics would be used?
What can be recommended for a fixed duration of 12 months instead of 12 months beyond culture conversion?
What can be recommended for a fixed duration of 12 months instead of 12 months beyond culture conversion?
What may be substituted for rifampin to reduce CYP 450 induction?
What may be substituted for rifampin to reduce CYP 450 induction?
Which best describes persisters?
Which best describes persisters?
Which best describes multi drug treatment?
Which best describes multi drug treatment?
Why are long durations required for Mycobacteria Disease Treatment?
Why are long durations required for Mycobacteria Disease Treatment?
Why is it important to identify NTM to the species level?
Why is it important to identify NTM to the species level?
What is the rationale behind using multiple drugs to treat mycobacterial infections?
What is the rationale behind using multiple drugs to treat mycobacterial infections?
What is a key reason that mycobacterial infections require long treatment durations?
What is a key reason that mycobacterial infections require long treatment durations?
What is the primary mechanism by which resistance to rifampin develops in Mycobacterium tuberculosis?
What is the primary mechanism by which resistance to rifampin develops in Mycobacterium tuberculosis?
A patient with HIV/TB co-infection is starting antiretroviral therapy (ART). When should TB treatment be initiated relative to ART?
A patient with HIV/TB co-infection is starting antiretroviral therapy (ART). When should TB treatment be initiated relative to ART?
What is a significant risk factor for developing non-tuberculous mycobacteria (NTM) infections?
What is a significant risk factor for developing non-tuberculous mycobacteria (NTM) infections?
What is the role of katG in the mechanism of action of isoniazid (INH)?
What is the role of katG in the mechanism of action of isoniazid (INH)?
What is a common opportunistic NTM that is often found in AIDS patients?
What is a common opportunistic NTM that is often found in AIDS patients?
Which strategy is essential for preventing the development of drug resistance in tuberculosis treatment?
Which strategy is essential for preventing the development of drug resistance in tuberculosis treatment?
Which statement best describes the mechanism of action of ethambutol?
Which statement best describes the mechanism of action of ethambutol?
How do spontaneous mutations contribute to drug resistance in M. tuberculosis?
How do spontaneous mutations contribute to drug resistance in M. tuberculosis?
How does rifampin interact with other drugs in the body?
How does rifampin interact with other drugs in the body?
What is the primary target of pyrazinamide?
What is the primary target of pyrazinamide?
Which of the following is true regarding the frequency of spontaneous mutations leading to drug resistance in M. tuberculosis?
Which of the following is true regarding the frequency of spontaneous mutations leading to drug resistance in M. tuberculosis?
Why is vitamin B6 (pyridoxine) often administered alongside isoniazid (INH)?
Why is vitamin B6 (pyridoxine) often administered alongside isoniazid (INH)?
In treating tuberculosis, how does Directly Observed Therapy (DOT) contribute to preventing drug resistance?
In treating tuberculosis, how does Directly Observed Therapy (DOT) contribute to preventing drug resistance?
What is Immune Reconstitution Inflammatory Syndrome (IRIS) in the context of HIV and TB co-infection?
What is Immune Reconstitution Inflammatory Syndrome (IRIS) in the context of HIV and TB co-infection?
What aspect of Mycobacterium tuberculosis cellular structure contributes the MOST to its resistance against many common antibiotics?
What aspect of Mycobacterium tuberculosis cellular structure contributes the MOST to its resistance against many common antibiotics?
Which diagnostic method primarily determines the drug susceptibility profile of Mycobacterium tuberculosis?
Which diagnostic method primarily determines the drug susceptibility profile of Mycobacterium tuberculosis?
What is meant by the term 'prodrug' regarding certain anti-TB medications?
What is meant by the term 'prodrug' regarding certain anti-TB medications?
What is a key characteristic of Non-tuberculous Mycobacteria (NTM) regarding their habitat?
What is a key characteristic of Non-tuberculous Mycobacteria (NTM) regarding their habitat?
What consideration is most helpful for treating a macrolide suceptible MAC?
What consideration is most helpful for treating a macrolide suceptible MAC?
What is the recommended antibiotic regimen for treating a Mycobacterium ulcerans infection, commonly known as Buruli ulcer?
What is the recommended antibiotic regimen for treating a Mycobacterium ulcerans infection, commonly known as Buruli ulcer?
How does altering efflux pump activity affect drug resistance in mycobacteria?
How does altering efflux pump activity affect drug resistance in mycobacteria?
Besides the more conventional TB antibiotics, what new drugs target MDR/XDR-TB?
Besides the more conventional TB antibiotics, what new drugs target MDR/XDR-TB?
Which factor contributes to the intrinsic antibiotic resistance observed in M. abscessus?
Which factor contributes to the intrinsic antibiotic resistance observed in M. abscessus?
What is a potential adverse effect associated with ethambutol?
What is a potential adverse effect associated with ethambutol?
Which of the following is best to recommend for a fixed duration of 12 months instead of 12 months beyond culture conversion for the treatment of M. kansasii?
Which of the following is best to recommend for a fixed duration of 12 months instead of 12 months beyond culture conversion for the treatment of M. kansasii?
What factor indicates that Rifabutin may be substituted for Rifampin?
What factor indicates that Rifabutin may be substituted for Rifampin?
For pulmonary TB treatment what is the standard regimen?
For pulmonary TB treatment what is the standard regimen?
What is the first step of latent TB treatment?
What is the first step of latent TB treatment?
For a slow growing Mycobacterium, what is the days needed to grow?
For a slow growing Mycobacterium, what is the days needed to grow?
Mycobacterium ulcerans starts as what?
Mycobacterium ulcerans starts as what?
Which test can be used on Latent and Active TB testing?
Which test can be used on Latent and Active TB testing?
Which test is used to check Active TB?
Which test is used to check Active TB?
Which two tests are used to monitor Drug susceptibility?
Which two tests are used to monitor Drug susceptibility?
Which infection can be observed through cervical lymphadenitis?
Which infection can be observed through cervical lymphadenitis?
Which of the following is a key characteristic differentiating pathogenic mycobacteria from opportunistic mycobacteria?
Which of the following is a key characteristic differentiating pathogenic mycobacteria from opportunistic mycobacteria?
A patient is diagnosed with a disseminated NTM infection. Which of the following species is MOST likely to be the causative agent?
A patient is diagnosed with a disseminated NTM infection. Which of the following species is MOST likely to be the causative agent?
Why is it important to use multiple drugs when treating active TB?
Why is it important to use multiple drugs when treating active TB?
How do spontaneous mutations in Mycobacterium tuberculosis contribute to the development of drug resistance?
How do spontaneous mutations in Mycobacterium tuberculosis contribute to the development of drug resistance?
What is the primary rationale for identifying NTM isolates to the species level?
What is the primary rationale for identifying NTM isolates to the species level?
What role does mycolic acid play in the characteristics of mycobacteria?
What role does mycolic acid play in the characteristics of mycobacteria?
Isoniazid (INH) requires activation within the mycobacterial cell to be effective. Which of the following enzymes is responsible for this activation?
Isoniazid (INH) requires activation within the mycobacterial cell to be effective. Which of the following enzymes is responsible for this activation?
Which of the following mechanisms describes how ethambutol exerts its antimycobacterial effect?
Which of the following mechanisms describes how ethambutol exerts its antimycobacterial effect?
Rifampin is known for its interactions with other drugs. What is the primary mechanism behind these interactions?
Rifampin is known for its interactions with other drugs. What is the primary mechanism behind these interactions?
A patient on rifampin develops symptoms of hepatitis. Which of the following actions is MOST appropriate?
A patient on rifampin develops symptoms of hepatitis. Which of the following actions is MOST appropriate?
Why is pyridoxine (vitamin B6) commonly administered alongside isoniazid (INH) in TB treatment?
Why is pyridoxine (vitamin B6) commonly administered alongside isoniazid (INH) in TB treatment?
Which of the following describes the action of pyrazinamide in treating tuberculosis?
Which of the following describes the action of pyrazinamide in treating tuberculosis?
How does resistance to pyrazinamide typically develop in Mycobacterium tuberculosis?
How does resistance to pyrazinamide typically develop in Mycobacterium tuberculosis?
A patient with HIV/TB co-infection is about to start antiretroviral therapy (ART). Their CD4 count is <50 cells/µL. According to guidelines, when should TB treatment be initiated relative to ART?
A patient with HIV/TB co-infection is about to start antiretroviral therapy (ART). Their CD4 count is <50 cells/µL. According to guidelines, when should TB treatment be initiated relative to ART?
What is the primary advantage of using rifabutin over rifampin in HIV/TB co-infected patients on protease inhibitors?
What is the primary advantage of using rifabutin over rifampin in HIV/TB co-infected patients on protease inhibitors?
According to current guidelines, what is the recommended treatment duration for latent TB infection (LTBI) using isoniazid and rifapentine?
According to current guidelines, what is the recommended treatment duration for latent TB infection (LTBI) using isoniazid and rifapentine?
Which of the following accurately describes the role of Directly Observed Therapy (DOT) in TB treatment?
Which of the following accurately describes the role of Directly Observed Therapy (DOT) in TB treatment?
Which diagnostic method is MOST useful for rapidly detecting resistance to rifampin in Mycobacterium tuberculosis?
Which diagnostic method is MOST useful for rapidly detecting resistance to rifampin in Mycobacterium tuberculosis?
Mycobacterium ulcerans, the causative agent of Buruli ulcer, is MOST commonly treated with which combination of antibiotics?
Mycobacterium ulcerans, the causative agent of Buruli ulcer, is MOST commonly treated with which combination of antibiotics?
Which best describes persisters regarding mycobacterial infections?
Which best describes persisters regarding mycobacterial infections?
A patient with a history of pulmonary disease is diagnosed with a Mycobacterium xenopi infection. Which of the following antibiotic regimens is MOST appropriate?
A patient with a history of pulmonary disease is diagnosed with a Mycobacterium xenopi infection. Which of the following antibiotic regimens is MOST appropriate?
What approach to drug administration is DOT?
What approach to drug administration is DOT?
Which of the following best explains why long durations are required for Mycobacteria Disease Treatment?
Which of the following best explains why long durations are required for Mycobacteria Disease Treatment?
Why is multi drug treatment required for Mycobacterial Diseases?
Why is multi drug treatment required for Mycobacterial Diseases?
NTMs are found ubiquitously in the environment. What is the main source?
NTMs are found ubiquitously in the environment. What is the main source?
Which of the listed diagnostic tests are used to check for active TB?
Which of the listed diagnostic tests are used to check for active TB?
Which of the following best describes a key aspect of TB incidence in the USA?
Which of the following best describes a key aspect of TB incidence in the USA?
What is the primary reason for identifying NTM isolates to the species level?
What is the primary reason for identifying NTM isolates to the species level?
A researcher is investigating the mechanism of action of a new drug targeting Mycobacterium tuberculosis. The drug inhibits the synthesis of arabinogalactan and lipoarabinomannan. Which existing anti-TB drug shares a similar mechanism of action?
A researcher is investigating the mechanism of action of a new drug targeting Mycobacterium tuberculosis. The drug inhibits the synthesis of arabinogalactan and lipoarabinomannan. Which existing anti-TB drug shares a similar mechanism of action?
A patient on rifampin begins experiencing signs of liver dysfunction. What is the MOST appropriate course of action?
A patient on rifampin begins experiencing signs of liver dysfunction. What is the MOST appropriate course of action?
A patient with TB is prescribed isoniazid (INH) and develops peripheral neuropathy. What is the mechanism by which pyridoxine (vitamin B6) helps to alleviate this side effect?
A patient with TB is prescribed isoniazid (INH) and develops peripheral neuropathy. What is the mechanism by which pyridoxine (vitamin B6) helps to alleviate this side effect?
What enzymatic activity of KatG is essential for converting Isoniazid into its active form in Mycobacterium tuberculosis?
What enzymatic activity of KatG is essential for converting Isoniazid into its active form in Mycobacterium tuberculosis?
Which statement accurately describes the mechanistic action of ethambutol in treating tuberculosis?
Which statement accurately describes the mechanistic action of ethambutol in treating tuberculosis?
How does the development of spontaneous mutations in Mycobacterium tuberculosis typically lead to drug resistance?
How does the development of spontaneous mutations in Mycobacterium tuberculosis typically lead to drug resistance?
What is the role of pyrazinoic acid in the mechanism of action of pyrazinamide against Mycobacterium tuberculosis?
What is the role of pyrazinoic acid in the mechanism of action of pyrazinamide against Mycobacterium tuberculosis?
Which factor is MOST crucial when deciding between rifampin and rifabutin for a patient with HIV/TB co-infection?
Which factor is MOST crucial when deciding between rifampin and rifabutin for a patient with HIV/TB co-infection?
How does the Directly Observed Therapy (DOT) method enhance the effectiveness of tuberculosis treatment in preventing drug resistance?
How does the Directly Observed Therapy (DOT) method enhance the effectiveness of tuberculosis treatment in preventing drug resistance?
What is a defining characteristic of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV/TB co-infected patients?
What is a defining characteristic of Immune Reconstitution Inflammatory Syndrome (IRIS) in HIV/TB co-infected patients?
What structural characteristic of Mycobacterium tuberculosis MOST significantly contributes to its resistance to many common antibiotics?
What structural characteristic of Mycobacterium tuberculosis MOST significantly contributes to its resistance to many common antibiotics?
Which approach enables the MOST rapid determination of rifampin resistance in Mycobacterium tuberculosis?
Which approach enables the MOST rapid determination of rifampin resistance in Mycobacterium tuberculosis?
Considering the complexity of treating drug-resistant TB, which of the following strategies is MOST effective in preventing the spread of resistance?
Considering the complexity of treating drug-resistant TB, which of the following strategies is MOST effective in preventing the spread of resistance?
A patient has been diagnosed with a non-tuberculous mycobacterial (NTM) infection caused by Mycobacterium abscessus with inducible Erm gene. How does inducible expression of the erythromycin ribosomal methylase (Erm) gene contribute to antibiotic resistance in this species?
A patient has been diagnosed with a non-tuberculous mycobacterial (NTM) infection caused by Mycobacterium abscessus with inducible Erm gene. How does inducible expression of the erythromycin ribosomal methylase (Erm) gene contribute to antibiotic resistance in this species?
Which statement BEST describes how persisters contribute to the challenge of treating mycobacterial infections?
Which statement BEST describes how persisters contribute to the challenge of treating mycobacterial infections?
What is the MOST critical reason for employing multi-drug therapy in the treatment of mycobacterial infections?
What is the MOST critical reason for employing multi-drug therapy in the treatment of mycobacterial infections?
What factor contributes MOST to the need for prolonged treatment durations in mycobacterial infections compared to other bacterial infections?
What factor contributes MOST to the need for prolonged treatment durations in mycobacterial infections compared to other bacterial infections?
How can increased activity of efflux pumps affect antibiotic effectiveness in mycobacteria?
How can increased activity of efflux pumps affect antibiotic effectiveness in mycobacteria?
A patient with Mycobacterium xenopi infection has cavitary lung disease with advanced bronchiectasis. Which of the following modifications to the standard treatment regimen should be considered?
A patient with Mycobacterium xenopi infection has cavitary lung disease with advanced bronchiectasis. Which of the following modifications to the standard treatment regimen should be considered?
What is a primary advantage of using rifabutin over rifampin in treating TB in HIV-positive patients who are also taking protease inhibitors?
What is a primary advantage of using rifabutin over rifampin in treating TB in HIV-positive patients who are also taking protease inhibitors?
According to current guidelines, what is the recommended treatment duration for the preferred regimen for latent TB infection (LTBI) using isoniazid and rifapentine?
According to current guidelines, what is the recommended treatment duration for the preferred regimen for latent TB infection (LTBI) using isoniazid and rifapentine?
Which diagnostic finding would MOST strongly suggest a diagnosis of active TB disease rather than latent TB infection?
Which diagnostic finding would MOST strongly suggest a diagnosis of active TB disease rather than latent TB infection?
Aside from conventional TB antibiotics, which new drugs are currently being used to target MDR/XDR-TB effectively?
Aside from conventional TB antibiotics, which new drugs are currently being used to target MDR/XDR-TB effectively?
Which of the following mutations is MOST likely to result in resistance to rifampin in Mycobacterium tuberculosis?
Which of the following mutations is MOST likely to result in resistance to rifampin in Mycobacterium tuberculosis?
Which of the following is the MOST appropriate initial treatment strategy for a localized skin infection caused by a rapidly growing mycobacteria (RGM) such as Mycobacterium fortuitum?
Which of the following is the MOST appropriate initial treatment strategy for a localized skin infection caused by a rapidly growing mycobacteria (RGM) such as Mycobacterium fortuitum?
An 8 year old is diagnosed with TB meningitis. What modification to the standard treatment would you recommend?
An 8 year old is diagnosed with TB meningitis. What modification to the standard treatment would you recommend?
A patient is infected with M. avium complex (MAC) but it is determined their strain is macrolide susceptible. What is the best recommendation for treatment?
A patient is infected with M. avium complex (MAC) but it is determined their strain is macrolide susceptible. What is the best recommendation for treatment?
Which is true for Mycobacterium ulcerans?
Which is true for Mycobacterium ulcerans?
Which of the following is a way in which M. tb becomes drug resistant?
Which of the following is a way in which M. tb becomes drug resistant?
What strategy is directly aimed at preventing the development of drug resistance in TB treatment by ensuring adherence?
What strategy is directly aimed at preventing the development of drug resistance in TB treatment by ensuring adherence?
For a slow growing mycobacterium, how many days are needed to grow in the lab setting?
For a slow growing mycobacterium, how many days are needed to grow in the lab setting?
For HIV patients with CD4 counts of less than 50, how long should you wait after TB treatment to start ART?
For HIV patients with CD4 counts of less than 50, how long should you wait after TB treatment to start ART?
For a macrolide resistant treatment, which medication would be recommended?
For a macrolide resistant treatment, which medication would be recommended?
What are the first two steps when undergoing treatment for latent TB?
What are the first two steps when undergoing treatment for latent TB?
A patient with TB has already failed a drug regimen that included rifampin. What should you avoid doing?
A patient with TB has already failed a drug regimen that included rifampin. What should you avoid doing?
Which diagnostic test can be used for Active and Latent TB?
Which diagnostic test can be used for Active and Latent TB?
What is the most common source for NTM infections?
What is the most common source for NTM infections?
Which are the two tests to check for drug susceptibility?
Which are the two tests to check for drug susceptibility?
A patient diagnosed with tuberculosis is prescribed isoniazid. The physician explains that isoniazid is a prodrug. What is the MOST significant implication of isoniazid being a prodrug for its mechanism of action?
A patient diagnosed with tuberculosis is prescribed isoniazid. The physician explains that isoniazid is a prodrug. What is the MOST significant implication of isoniazid being a prodrug for its mechanism of action?
Rifampin is known to induce hepatic cytochrome P450 enzymes. Considering this pharmacological property, what is the MOST critical clinical implication when initiating rifampin therapy in a patient already receiving protease inhibitors for HIV?
Rifampin is known to induce hepatic cytochrome P450 enzymes. Considering this pharmacological property, what is the MOST critical clinical implication when initiating rifampin therapy in a patient already receiving protease inhibitors for HIV?
Ethambutol's mechanism of action involves the inhibition of arabinosyltransferases, affecting the synthesis of arabinogalactan and lipoarabinomannan. Which of the following cellular structures in Mycobacterium tuberculosis is DIRECTLY compromised by this mechanism?
Ethambutol's mechanism of action involves the inhibition of arabinosyltransferases, affecting the synthesis of arabinogalactan and lipoarabinomannan. Which of the following cellular structures in Mycobacterium tuberculosis is DIRECTLY compromised by this mechanism?
Pyrazinamide is uniquely effective against Mycobacterium tuberculosis in the acidic environment of the phagolysosome. What is the MOST likely reason for this specific activity in acidic conditions?
Pyrazinamide is uniquely effective against Mycobacterium tuberculosis in the acidic environment of the phagolysosome. What is the MOST likely reason for this specific activity in acidic conditions?
A patient with active pulmonary tuberculosis is started on a standard 6-month regimen. After two months, a follow-up sputum culture is still positive for M. tuberculosis. However, drug susceptibility testing from the initial isolate shows sensitivity to all first-line drugs. What is the MOST probable explanation for the persistent positive culture at this stage of treatment?
A patient with active pulmonary tuberculosis is started on a standard 6-month regimen. After two months, a follow-up sputum culture is still positive for M. tuberculosis. However, drug susceptibility testing from the initial isolate shows sensitivity to all first-line drugs. What is the MOST probable explanation for the persistent positive culture at this stage of treatment?
Directly Observed Therapy (DOT) is a critical strategy in tuberculosis treatment. What is the PRIMARY rationale for recommending DOT for patients with active TB?
Directly Observed Therapy (DOT) is a critical strategy in tuberculosis treatment. What is the PRIMARY rationale for recommending DOT for patients with active TB?
Mycobacterium abscessus is known for its intrinsic resistance to several antibiotics. Which of the following mechanisms contributes MOST significantly to the inherent antibiotic resistance observed in M. abscessus?
Mycobacterium abscessus is known for its intrinsic resistance to several antibiotics. Which of the following mechanisms contributes MOST significantly to the inherent antibiotic resistance observed in M. abscessus?
A patient with HIV and newly diagnosed active tuberculosis has a CD4 count of 40 cells/µL. According to current guidelines, when should antiretroviral therapy (ART) be initiated relative to the start of tuberculosis treatment to optimize clinical outcomes and minimize complications like IRIS?
A patient with HIV and newly diagnosed active tuberculosis has a CD4 count of 40 cells/µL. According to current guidelines, when should antiretroviral therapy (ART) be initiated relative to the start of tuberculosis treatment to optimize clinical outcomes and minimize complications like IRIS?
Immune Reconstitution Inflammatory Syndrome (IRIS) is a potential complication in HIV/TB co-infected patients initiating antiretroviral therapy (ART). What is the underlying immunological mechanism that BEST explains the development of paradoxical TB-IRIS?
Immune Reconstitution Inflammatory Syndrome (IRIS) is a potential complication in HIV/TB co-infected patients initiating antiretroviral therapy (ART). What is the underlying immunological mechanism that BEST explains the development of paradoxical TB-IRIS?
Mycobacterium ulcerans, the causative agent of Buruli ulcer, is unique among pathogenic mycobacteria due to its production of mycolactone. What is the PRIMARY role of mycolactone in the pathogenesis of Buruli ulcer?
Mycobacterium ulcerans, the causative agent of Buruli ulcer, is unique among pathogenic mycobacteria due to its production of mycolactone. What is the PRIMARY role of mycolactone in the pathogenesis of Buruli ulcer?
In the treatment of Mycobacterium kansasii pulmonary disease, current guidelines recommend a fixed duration of 12 months of therapy instead of the traditional approach of 12 months beyond culture conversion. What is the PRIMARY rationale for this fixed duration approach in M. kansasii infections?
In the treatment of Mycobacterium kansasii pulmonary disease, current guidelines recommend a fixed duration of 12 months of therapy instead of the traditional approach of 12 months beyond culture conversion. What is the PRIMARY rationale for this fixed duration approach in M. kansasii infections?
A patient is diagnosed with Mycobacterium xenopi pulmonary disease. Considering the challenges in treating this NTM species and its association with poorer outcomes, what modification to the standard NTM treatment regimen is MOST critical to consider in patients with cavitary lung disease and advanced bronchiectasis?
A patient is diagnosed with Mycobacterium xenopi pulmonary disease. Considering the challenges in treating this NTM species and its association with poorer outcomes, what modification to the standard NTM treatment regimen is MOST critical to consider in patients with cavitary lung disease and advanced bronchiectasis?
In the context of drug resistance in Mycobacterium tuberculosis, mutations in the rpoB gene are frequently associated with resistance to rifampin. What is the MOST direct consequence of rpoB mutations on the mechanism of action of rifampin?
In the context of drug resistance in Mycobacterium tuberculosis, mutations in the rpoB gene are frequently associated with resistance to rifampin. What is the MOST direct consequence of rpoB mutations on the mechanism of action of rifampin?
For a patient with pulmonary disease caused by Mycobacterium avium complex (MAC) that is determined to be macrolide-susceptible, which of the following antibiotic classes would be considered the CORNERSTONE of the recommended multi-drug treatment regimen?
For a patient with pulmonary disease caused by Mycobacterium avium complex (MAC) that is determined to be macrolide-susceptible, which of the following antibiotic classes would be considered the CORNERSTONE of the recommended multi-drug treatment regimen?
A clinical microbiology laboratory is processing a sputum sample suspected of containing mycobacteria. For a slow-growing mycobacterium, such as Mycobacterium tuberculosis or Mycobacterium avium complex, what is the MINIMUM number of days typically required for visible colony growth on solid culture media to allow for identification and drug susceptibility testing?
A clinical microbiology laboratory is processing a sputum sample suspected of containing mycobacteria. For a slow-growing mycobacterium, such as Mycobacterium tuberculosis or Mycobacterium avium complex, what is the MINIMUM number of days typically required for visible colony growth on solid culture media to allow for identification and drug susceptibility testing?
A patient presents with cervical lymphadenitis, and subsequent diagnostic workup reveals infection with a non-tuberculous mycobacterium. Which of the following NTM species is MOST frequently associated with cervical lymphadenitis, particularly in children?
A patient presents with cervical lymphadenitis, and subsequent diagnostic workup reveals infection with a non-tuberculous mycobacterium. Which of the following NTM species is MOST frequently associated with cervical lymphadenitis, particularly in children?
When initiating treatment for latent tuberculosis infection (LTBI), what are the FIRST two critical steps that should be undertaken to ensure appropriate management and prevent progression to active disease?
When initiating treatment for latent tuberculosis infection (LTBI), what are the FIRST two critical steps that should be undertaken to ensure appropriate management and prevent progression to active disease?
A patient with active tuberculosis is being treated with a regimen including rifampin. They also take several other medications for chronic conditions. Which of the following drug interactions is MOST concerning due to rifampin's known pharmacological properties?
A patient with active tuberculosis is being treated with a regimen including rifampin. They also take several other medications for chronic conditions. Which of the following drug interactions is MOST concerning due to rifampin's known pharmacological properties?
Mycobacterium ulcerans infection, or Buruli ulcer, typically manifests initially as a painless nodule on the skin. What is the MOST characteristic progression of this nodule if left untreated?
Mycobacterium ulcerans infection, or Buruli ulcer, typically manifests initially as a painless nodule on the skin. What is the MOST characteristic progression of this nodule if left untreated?
In the context of tuberculosis treatment, why is it generally contraindicated to add only a SINGLE new anti-TB drug to a failing treatment regimen where there is evidence of ongoing bacterial replication and lack of clinical improvement?
In the context of tuberculosis treatment, why is it generally contraindicated to add only a SINGLE new anti-TB drug to a failing treatment regimen where there is evidence of ongoing bacterial replication and lack of clinical improvement?
Which of the following diagnostic tests is MOST appropriate for RAPIDLY detecting rifampin resistance in Mycobacterium tuberculosis directly from a sputum sample, enabling timely adjustments to the treatment regimen?
Which of the following diagnostic tests is MOST appropriate for RAPIDLY detecting rifampin resistance in Mycobacterium tuberculosis directly from a sputum sample, enabling timely adjustments to the treatment regimen?
For patients with disseminated infections caused by non-tuberculous mycobacteria (NTM), particularly in the context of advanced HIV/AIDS, which NTM species is MOST frequently identified as the causative agent?
For patients with disseminated infections caused by non-tuberculous mycobacteria (NTM), particularly in the context of advanced HIV/AIDS, which NTM species is MOST frequently identified as the causative agent?
A patient with pulmonary Mycobacterium xenopi infection also has advanced bronchiectasis and cavitary lung disease. Considering these complicating factors, what is the MOST important adjustment to the standard M. xenopi treatment regimen to optimize therapeutic outcomes?
A patient with pulmonary Mycobacterium xenopi infection also has advanced bronchiectasis and cavitary lung disease. Considering these complicating factors, what is the MOST important adjustment to the standard M. xenopi treatment regimen to optimize therapeutic outcomes?
What is the MOST significant clinical advantage of using rifabutin over rifampin in the treatment of tuberculosis for HIV-positive patients who are concurrently receiving protease inhibitors (PIs) as part of their antiretroviral therapy?
What is the MOST significant clinical advantage of using rifabutin over rifampin in the treatment of tuberculosis for HIV-positive patients who are concurrently receiving protease inhibitors (PIs) as part of their antiretroviral therapy?
For pulmonary tuberculosis, what is generally considered the STANDARD intensive phase regimen in current daily treatment guidelines for drug-sensitive TB?
For pulmonary tuberculosis, what is generally considered the STANDARD intensive phase regimen in current daily treatment guidelines for drug-sensitive TB?
Which of the following BEST describes the phenomenon of 'persisters' in the context of mycobacterial infections and their contribution to the challenges in treatment?
Which of the following BEST describes the phenomenon of 'persisters' in the context of mycobacterial infections and their contribution to the challenges in treatment?
Flashcards
Latent TB vs. Active TB: Diagnostics
Latent TB vs. Active TB: Diagnostics
In latent TB, the tuberculin skin test (PPD) and interferon-gamma release assay (IGRA) are positive, chest X-ray is normal, and there are no symptoms; in active TB, PPD/IGRA are usually positive, chest X-ray may show abnormalities, and symptoms like cough, fever, and weight loss are present.
Drugs for Drug-Susceptible TB
Drugs for Drug-Susceptible TB
Isoniazid, rifampin, ethambutol, and pyrazinamide are used for 6 months; the initial phase involves all four drugs for 2 months, followed by isoniazid and rifampin for 4 months.
Drugs for Drug-Resistant TB
Drugs for Drug-Resistant TB
Bedaquiline, delamanid, linezolid, clofazimine, and moxifloxacin
TB-Activated Prodrugs
TB-Activated Prodrugs
Signup and view all the flashcards
Why Use Multiple Drugs
Why Use Multiple Drugs
Signup and view all the flashcards
No Monotherapy
No Monotherapy
Signup and view all the flashcards
Acid-Fastness in Mycobacteria
Acid-Fastness in Mycobacteria
Signup and view all the flashcards
Pathogenic Mycobacteria
Pathogenic Mycobacteria
Signup and view all the flashcards
Sources of NTMs
Sources of NTMs
Signup and view all the flashcards
Risk Factors for NTM Infection
Risk Factors for NTM Infection
Signup and view all the flashcards
NTM Diagnostic Criteria
NTM Diagnostic Criteria
Signup and view all the flashcards
NTM Classification
NTM Classification
Signup and view all the flashcards
MAC Treatment
MAC Treatment
Signup and view all the flashcards
M. kansasii Treatment
M. kansasii Treatment
Signup and view all the flashcards
Challenges of M. Xenopi treatment
Challenges of M. Xenopi treatment
Signup and view all the flashcards
M. ulcerans treatment
M. ulcerans treatment
Signup and view all the flashcards
Why long duration for mycobacterial tx
Why long duration for mycobacterial tx
Signup and view all the flashcards
Efflux pumps description
Efflux pumps description
Signup and view all the flashcards
Fluoroquinolones MOA
Fluoroquinolones MOA
Signup and view all the flashcards
Acquired resistance
Acquired resistance
Signup and view all the flashcards
Mycobacteria staining
Mycobacteria staining
Signup and view all the flashcards
What is Tuberculosis?
What is Tuberculosis?
Signup and view all the flashcards
Drug Resistance Definitions
Drug Resistance Definitions
Signup and view all the flashcards
Active TB
Active TB
Signup and view all the flashcards
What is Phagocytosis?
What is Phagocytosis?
Signup and view all the flashcards
Non-tuberculous mycobacteria (NTM) infections
Non-tuberculous mycobacteria (NTM) infections
Signup and view all the flashcards
TB first line treatment
TB first line treatment
Signup and view all the flashcards
rpoB target
rpoB target
Signup and view all the flashcards
katG
katG
Signup and view all the flashcards
INH Metabolism
INH Metabolism
Signup and view all the flashcards
Enzyme Induction
Enzyme Induction
Signup and view all the flashcards
Ethambutol toxicity
Ethambutol toxicity
Signup and view all the flashcards
Bacterial-activated prodrugs
Bacterial-activated prodrugs
Signup and view all the flashcards
First line treatment with Rifabutin
First line treatment with Rifabutin
Signup and view all the flashcards
M. xenopi first step
M. xenopi first step
Signup and view all the flashcards
MAC Infection
MAC Infection
Signup and view all the flashcards
Efflux Pumps
Efflux Pumps
Signup and view all the flashcards
Erm Dependent Treatment
Erm Dependent Treatment
Signup and view all the flashcards
Erm Dependent Treatment
Erm Dependent Treatment
Signup and view all the flashcards
TB acronyms
TB acronyms
Signup and view all the flashcards
INH full name
INH full name
Signup and view all the flashcards
What are Non-tuberculous mycobacteria (NTM)?
What are Non-tuberculous mycobacteria (NTM)?
Signup and view all the flashcards
NTM Disease: A Growing Concern
NTM Disease: A Growing Concern
Signup and view all the flashcards
Where are NTMs found?
Where are NTMs found?
Signup and view all the flashcards
NTM Treatment: Multidrug Therapy
NTM Treatment: Multidrug Therapy
Signup and view all the flashcards
NTM Classification: Growth Rate
NTM Classification: Growth Rate
Signup and view all the flashcards
MAC Treatment Regimen
MAC Treatment Regimen
Signup and view all the flashcards
Immune Reconstitution Inflammatory Syndrome (IRIS)
Immune Reconstitution Inflammatory Syndrome (IRIS)
Signup and view all the flashcards
Mycolic Acid
Mycolic Acid
Signup and view all the flashcards
Drug Resistance Mechanisms in TB
Drug Resistance Mechanisms in TB
Signup and view all the flashcards
Pyrazinamide Resistance
Pyrazinamide Resistance
Signup and view all the flashcards
Isoniazid (INH) Dosage & Side Effects
Isoniazid (INH) Dosage & Side Effects
Signup and view all the flashcards
Ethambutol Mechanism of Action
Ethambutol Mechanism of Action
Signup and view all the flashcards
Rifampin Concerns
Rifampin Concerns
Signup and view all the flashcards
HIV/TB Treatment Integration
HIV/TB Treatment Integration
Signup and view all the flashcards
Study Notes
- Anti-Mycobacterial agents treat Tuberculosis and non-tuberculous Mycobacteria (NTM).
Mycobacteria Overview
- Mycobacteria are acid-fast due to mycolic acid in their cell walls.
- There are over 190 species of mycobacteria.
- Opportunistic mycobacteria include NTM.
- Pathogenic mycobacteria include:
- M. tuberculosis (Tuberculosis).
- M. bovis (Tuberculosis).
- M. leprae (Leprosy).
- M. ulcerans (Buruli ulcers).
- NTM can be rapid or slow-growing and cause ubiquitous infections.
- NTM infections can be:
- Respiratory
- Disseminated
- Cutaneous
Global TB Statistics
- A total of 2 billion people are infected with TB.
- There are 10.8 million new TB cases per year.
- Isoniazid and Rifampin resistance stands at 400,000 cases.
- Fluoroquinolones and injectables resistance stands at approximately 13,500 cases.
- Drug-sensitive TB treatment lasts 4-6 months.
- MDR/RR-TB needs 6-18 months.
- XDR-TB needs 6-24+ months
- Drug sensitive TB treatment has an 86% success rate.
- MDR/RR-TB treatment has a variable success rate, regimen-dependent.
- TB deaths total 1.25 million, including 161,000 with HIV.
- An estimated 170,000 deaths due to drug resistant TB.
Global Distribution
- High TB incidence rates in 2022 were particularly seen in Africa and Southeast Asia.
- In 2023, countries with at least 100,000 incident TB cases included:
- China
- India
- Indonesia
- Nigeria
- Pakistan
- Democratic Republic of the Congo
- Bangladesh
- Philippines
US Statistics
- In the United States in 2023, there were 9,633 TB cases.
- Incidence rates varied by state, with Alaska reporting 10.5 cases per 100,000 persons, while Massachusetts had 3.2.
Infection, Latency, and Disease
- TB is transmitted via airborne droplets.
- Bacilli are coughed or exhaledby an active case as droplet nuclei
- Latent TB infection (LTBI):
- Bacteria lie dormant
- The infected individual is asymptomatic.
- A tuberculin skin test (PPD) or QuantiFERON test will yield a positive result.
- 2 billion people are infected.
- Granuloma formation occurs.
- 10% cases activate in lifetime, and 10% cases in immunocompromised individuals activate per year.
- Active TB disease:
- Characterized by bacterial multiplication.
- Weight loss, fever, and cough are common symptoms.
- A PPD test , chest X ray and culture + smear will all likely produce a positive result.
- There are 30 million cases worldwide.
Clinical Syndromes
- Tuberculosis (TB) infections are mostly restricted to the lungs, with potential involvement of any organ.
- Insidious onset.
- Nonspecific symptoms include malaise, weight loss, night sweats, and cough.
- Hemoptysis (coughing up blood) may occur.
- Sputum production may be scant or bloody and purulent.
- Sputum with hemoptysis is associated with tissue destruction.
TB Diagnostics
-
Tuberculin (PPD) Skin Test
- Influenced by BCG vaccination
- Used for both latent and active infection detection.
-
Y-Interferon Release Assay (e.g. Quantiferon Gold):
- Used for both latent and active infection detection.
-
Chest X-ray:
- Used for active infection detection and treatment monitoring.
-
Sputum Smear Microscopy:
- Acid-fast stain with low sensitivity
- Used for active infection detection and treatment monitoring.
-
Culture (e.g. LJ agar, 3-6 weeks):
- Used for detection, drug susceptibility testing, and treatment monitoring.
-
Culture/Metabolism (e.g. MGIT, 1-2 weeks):
- Used for active infection detection, drug susceptibility testing, and treatment monitoring.
-
PCR (e.g. Xpert MTB/RIF, 2 hours): -Detects active infection and Rifampin resistance.
-
Next Gen Sequencing (e.g. Deeplex MycTB): -All drug susceptibility testing.
Mycobacterium Tuberculosis Profile
- Ancient pathogen.
- Acid-fast.
- Very slow growth.
- Complex cell wall.
- Approximately 4,000 genes.
- Aerobic/anaerobic.
- Intracellular/extracellular.
- Resistant to many common antibiotics.
- No environmental reservoir.
Cell Wall Structure Comparison
- M. tuberculosis has an acid-fast cell wall, which is different from Gram-positive (S. aureus) and Gram-negative (E. coli) bacteria.
- Acid fast cell wall contains Mycolic acid, Arabinofuranose, Galactofuranose, and Peptidoglycan
Active TB Treatment Regimens (Drug-Sensitive)
- Six-month regimen:
- Intensive phase:
- Two months of Isoniazid (INH).
- Rifampin
- Ethambutol
- Pyrazinamide
- Continuation phase:
- Four months of Isoniazid (INH)
- Rifampin
- Four-month regimen:
- Intensive phase:
- Two months of Isoniazid (INH)
- Rifapentine
- Moxifloxacin
- Pyrazinamide
- Continuation phase:
- Two months of Isoniazid (INH)
- Rifapentine
- Moxifloxacin
Bacterial Subpopulations
- TB drugs target different subpopulations of bacteria in various environments, such as cavities and areas with varying acidity.
- INH, Rifampin, & Ethambutol target different subpopulations.
- Pyrazinamide targets bacteria in acid environments
- Rifampin and bedaquiline also target their own subpopulations.
Mechanisms of Drug Resistance
- Drug resistance in M. tb develop through spontaneous mutations that alter:
- The drug target.
- The quantity of the target.
- TB enzymes activation.
- The ability of the drug to enter M. tb.
Preventing Drug Resistance
- Strategies to prevent the development of drug resistance include:
- DOTS (Directly Observed Therapy).
- Fixed-dose combinations (INH, RIF, PZA +/- EMB).
- Drug susceptibility testing.
- Never add one drug to a failing regimen.
First-Line TB Agents
- Isoniazid.
- Rifampin or Rifapentine.
- Pyrazinamide.
- Ethambutol.
- Moxifloxacin.
Isoniazid (INH) and Ethionamide (ETH)
- Bacterial-activated prodrugs:
- Isoniazid: catalase-peroxidase katG.
- Ethionamide: monooxygenase ethA.
- Activated drug covalently binds NADH.
- Drug-NAD adduct binds long-chain NAD-dependent enoyl-ACP reductase (inhA) at the NADH binding site.
- Inhibits mycolic acid synthesis (C60-90 alpha-alkyl, beta-hydroxy fatty acids).
INH Resistance
- Frequency: 4% primary, 11% acquired.
- katG, missense or large deletions in catalase-peroxidase (65% of isolates).
- inhA, mutations in NADH binding site (20% of clinical isolates).
INH Pharmacology
- Dosage is 5 mg/kg or 300 mg PO daily.
- Cmax is 7 ug/ml with an MIC of 0.05-0.2 ug/ml.
- Half-life (T1/2) is 0.5 – 5 hours, with rapid acetylators at 0.5-1.5 hours and slow acetylators at 2-4 hours.
- Side effects include Peripheral neuritis (managed with B6 pyridoxine at 15-50 mg/d) and hepatotoxicity.
Rifamycins: Rifampin (Rifampicin)
- Binds to the beta-subunit (rpoB) of RNA polymerase, changing its conformation.
- Prevents nucleotides from binding, inhibiting transcription initiation.
- Resistance develops through single amino acid substitutions in the rpoB hotspot with a primary resistance of 0.2% and acquired resistance of 2.5%.
Rifampin Pharmacology
- Dosage: 600 mg PO.
- Cmax: 8-10 ug/ml (MIC = 0.05-0.25 ug/ml).
- T1/2: 2.5-5h.
- Toxicity: Hepatitis.
- Induction of liver enzymes reduces the half-life of:
- Various steroids.
- Anticoagulants.
- Antimicrobials like macrolides and imidazoles.
- Protease inhibitors and NNRTIs.
Other Rifamycins
- Rifabutin:
- Less activation of P450, preferred for HIV/TB co-infection when using protease inhibitors, and used for M. avium-intracellulare infection.
- Rifapentine:
- Longer half-life (13 hours), potential for use in intermittent regimens, but is not active against rifampin-resistant TB.
Pyrazinamide
- Sterilizing activity, which shortens treatment from 9 to 6 months.
- Only active in vitro at low pH (<6).
- TB-specific (M.tb has deficient efflux).
- Activated by pyrazinamidase (pncA) to pyrazinoic acid.
- Resistance: pncA mutations.
- MOA: pyrazinoic acid binds to and promotes the degradation of aspartate decarboxylase (panD) by the CIpP protease system, inhibiting CoA biosynthesis.
Pyrazinamide Pharmacology
- Dose: 1g bid or tid
- Cmax : 45 ug/ml
- T1/2: 9-10h
- Metabolites: pyrazinoic acid, 5-hyroxypyrazinoic acid
- Adverse reactions:
- Significant hepatotoxicity -Elevated alanine and aspartate aminotransferase -Stomach upset
Ethambutol
- Inhibits arabinosyl transferase affecting the synthesis of arabinogalactan and lipoarabinomannan in the cell wall.
- Resistance occurs through overexpression and mutations, with primary resistance at 0.1% and acquired resistance at 1.8%.
Ethambutol Pharmacology
- Dosage: 25 mg/kg PO.
- Cmax: 2-5 ug/ml (MIC = 1-5 ug/ml).
- T1/2: 4h.
- Toxicity: few, optic neuritis (visual acuity, red-green differentiation).
Fluoroquinolones
- Synthetic derivatives of nalidixic acid.
- Inhibit DNA gyrase (ATP-dependent type II DNA topoisomerase) which catalyzes negative supercoiling of DNA.
- Resistance develops through mutations in the gyrA subunit, with the level of resistance correlated to specific mutations.
- Moxifloxacin
- Levofloxacin
- Aortic dissection/aneurysm
Newer Drugs for MDR/XDR-TB
Class | Existing drugs for other infections | Mycobacterial or TB-specific |
---|---|---|
Drug | Fluoroquinolones (Moxifloxacin) | Diarylquinoline (Bedaquiline) |
Oxazolidinone (Linezolid) | Nitroaromatic (Pretomanid, Delamanid) | |
MDR/XDR | MDR | MDR/XDR |
Spectrum | Broad (Moxifloxacin), G+ (Linezolid) | Mycobacteria, TB |
Target | DNA replication (Moxifloxacin), Ribosome (Linezolid) | ATP synthase, multiple (Pretomanid, Delamanid) |
Advantage | Widely available | Shortens Tx |
Disadvantage | Resistance exists | BM tox (Linezolid), Cardio tox (Bedaquiline) |
Next Gen | None | TBI-223, TBAJ587, TBAJ876 |
Treatment of Highly Drug-Resistant TB
- Recent clinical trials (Nix-TB, ZeNix, Practcal) support 6 month, all oral regimens using BPaL.
- BPaL regimen:
- Bedaquiline 200 mg qd x 8 weeks, then 100 mg x 18 weeks.
- Pretomanid 200 mg qd.
- Linezolid 600 mg qd (reduced dosage = reduced adverse reactions).
- BPaLM regimen:
- BPaL + moxifloxacin 400 mg qd.
- BPaL regimen:
Current Status of New TB Drug Development
- Emphasizing oral regimens, shorter treatments, and activity against drug-resistant TB.
Latent TB Treatment Options
- INH daily - 6-9 months.
- RMP daily - 4 months.
- INH + rifampin daily - 3 months.
- INH + rifapentine daily - 1 month.
- INH + rifapentine weekly - 3 months.
Extrapulmonary TB
- Standard treatment consists of a standard regimen with a continuation phase of 4-7 months.
- TB meningitis treatment:
- includes a standard regimen with a continuation phase of up to 10 months.
- Dexamethasone or prednisolone tapered over 6-8 weeks reduces mortality.
- Replace ethambutol with ethionamide or an aminoglycoside during the intensive phase for pediatric TB meningitis.
HIV & TB
- Immune Reconstitution Inflammatory Syndrome (IRIS):
- Characterized by high fevers, worsening respiratory symptoms, inflamed lymph nodes, new lymphadenopathy, expanding CNS lesions, worsening pulmonary parenchymal infiltrations, new/increasing pleural effusions, and intra-abdominal or retroperitoneal abscesses.
- Treat with ibuprofen (mild) or corticosteroid (severe).
- For patients receiving ART: Use the standard regimen.
- If CD4 count is 50. Withhold ART for 2 and 8-12 weeks where TB Tx began.
- If not receiving ART, extend continuation phase for 3 additional months.
- Avoid intermittent regimens.
- Rifabutin may be substituted for rifampin to reduce CYP 450 induction.
Key Abbreviations
- AFB - acid-fast bacilli.
- BCG – Bacillus Calmette-Guerin (vaccine strain of M. bovis).
- DOTS - directly observed therapy.
- DST - drug susceptibility testing.
- FAS - fatty acid synthase complex.
- MDR-TB - multi-drug resistant TB.
- MOTT - mycobacteria other than tuberculosis.
Key Drugs Abbreviations
- INH - isoniazid.
- CS - cycloserine.
- EMB - ethambutol.
- PAS - para-aminosalicylic acid.
- RIF or RMP - rifampin.
- RBT, RFB - rifabutin.
- RPT - rifapentene.
- SM - streptomycin.
- PZA - pyrazinamide.
Non-Tuberculous Mycobacteria (NTM)
- NTMs are opportunistic.
- Water is the main source where patients can acquire NTM by inhalation.
- Warmer climates have higher infection rates.
- Increased incidents have been most common in Hawaii, USA.
- Patient to patient transmission is possible but rare.
- Healthy lungs can clear NTM bacteria.
Risk Factors
- Immunosuppression (HIV, medications).
- Aging.
- Cystic Fibrosis.
- History of lung conditions.
- Bronchiectasis.
- Chronic Obstructive Pulmonary Disease (COPD).
- Chronic Obstructive Pulmonary Disease (COPD).
- Inherited and acquired defects in host immune response.
NTM Infections
- NTM Infections occur mostly in
- The lungs
- Cervical Lymphadenitits
- Bones
- Joints
- Soft Tissues
- NTM can also disseminate.
NTM Diagnosis
- Three or more sputum specimens are needed for AFB analysis.
- Chest radiograph or HRT test will likely be requested.
- TB must be excluded as a possibility.
- NTM should be identified to the species level.
NTM Classification
- Slow Growing Mycobacterium (SGM) (≥ 7 days to grow):
- Includes:
- M. avium complex.
- M. kansasii.
- M. xenopi.
- Rapidly Growing Mycobacterium (RGM) (< 7 days to grow):
- Includes:
- M. abscessus.
- M. fortuitum.
- M. chelonae.
- Includes:
Treatment of NTMs
- M. avium, M. intracellulare, M. chimaera treatment:
- Most commonly isolated NTM
- Routes of infection include ingestion of contaminated water and inhalation of MAC-containing aerosols.
- Principal cause of pulmonary disease (#1 cause in AIDS patients in the US)
- M. avium Complex (MAC) Treatment:
- Ethambutol
- Rifampin
- In those susceptible to macrolide, Azithromycin or clarithromycin can be used.
- In those macrolide resistant, Streptomycin or amikacin can be used.
- Administered for at least 12 months after culture conversion.
- *M. kansasii *:
- Treatment includes Rifampin, Ethambutol, and Isoniazid or Macrolide
- Fluoroquinolone or Aminoglycoside considerations can be made depending on resistance.
- Recommended for a fixed duration of 12 months.
- M. xenopi:
- Treatment includes Rifampin and Ethambutol including Macrolide or Fluoroquinolone.
- Amikacin or streptomycin can be used in extreme causes
- Optimal treatment is unknown. The 2007 guidelines stated that one would treat for 12 months beyond culture conversion.
NTMs - Rapidly Growing Mycobacteria (RGM)
- Species and their Common Clinical Diseases:
- M. fortuitum group:
- Localized posttraumatic infections
- Catheter Infections
- Augmentation mammaplasty
- Surgical Wound Infections
- M. chelonae:
- Disseminated Skin Infections
- Localized Posttraumatic Wound Infections
- Sinusitis
- Catheter Infections
- Corneal Infections
- M. abscessus:
- Chronic Lung Infections
- Localized posttraumatic wound infections
- Disseminated Skin Infection
- Catheter Infections
- Surgical Wound Infections
Mycobacterium Abscessus
- 2nd-3rd most common cause of lung disease due to NTM and the most common cause of lung disease due to a rapid grower.
- Highly resistant to antibiotics with current in vitro methods.
- The cure rate with pulmonary infection is only 25-58%.
erm Gene-Dependent Treatments of M. abscessus
- The difference between M. massiliense and M. abcessus dictates erm Dependent Treatments.
- Those without the erm gene like M Massiliense have
- Macrolide -2 other drugs for it to work effectively
- Those with the erm like abcessus have - Imipenem, Cefoxitin and Tigecycline with linezolid and Moxifloxacin.
Why Long Durations Are Required For Mycobacteria Treatment
- Due to the differing subpopulations of Mycobacteria:
- Exist in Extracellular environments
- Exist Intracellular during Non replicating phases
- Existence of Persisters and Biofilms
- Inhaled NTM can live extracellularly forming biofilm colonies damaging the lungs.
Why Multidrug Treatment is Required for Mycobacterial Diseases
- Due to
- Intrinsic Antibiotic Resistance
- Efflux pumps -Morphotypic resistance. Where one mutation can alter the functionality of another antibiotic.
Antibiotics and Their Targets
- The cell wall contains a multitude of Drug targets that will kill infections.
NTM Study Points
- Pulmonary diseases due to NTM are an increasing global health concern.
- Prevalence of NTM is increasing in the US.
- Diagnosis and successful treatment for NTMs is complicated.
- Effective new drugs and vaccines are needed.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.